Neurodegeneration: Paying it off with sleep

Current Biology

Volumn 25, Issue 6, 2015, Pages R234-R236

  Keene, Alex C ^a   Joiner, William J ^b  

^a UNIVERSITY OF NEVADA   (United States)

^b San Diego   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL; DISEASE MODEL; DROSOPHILA MELANOGASTER; GENETICS; HUMAN; NERVE DEGENERATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SLEEP; SLEEP DEPRIVATION; TRANSGENIC ANIMAL;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; HUMANS; NERVE DEGENERATION; SLEEP; SLEEP DEPRIVATION;

EID: 84926328800     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2015.02.003     Document Type: Short Survey

References (19)

1. B. Spencer, and E. Masliah Immunotherapy for Alzheimer's disease: past, present and future Front. Aging Neurosci. 6 2014 114
2. Y.E. Ju, B.P. Lucey, and D.M. Holtzman Sleep and Alzheimer disease pathology-a bidirectional relationship Nat. Rev. Neurol. 10 2014 115 119
3. M. Tabuchi, S.R. Lone, S. Liu, O. Liu, J. Zhang, A.P. Spira, and M.N. Wu Sleep interacts with Abeta to modulate intrinsic neuronal excitability Curr. Biol. 25 2015 702 712
4. L. Bertram, and R.E. Tanzi Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses Nat. Rev. Neurosci. 9 2008 768 778
5. C.R. Jack Jr., and D.M. Holtzman Biomarker modeling of Alzheimer's disease Neuron 80 2013 1347 1358
6. J.H. Roh, H. Jiang, M.B. Finn, F.R. Stewart, T.E. Mahan, J.R. Cirrito, A. Heda, B.J. Snider, M. Li, and M. Yanagisawa Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer's disease J. Exp. Med. 211 2014 2487 2496
7. M. Moran, C.A. Lynch, C. Walsh, R. Coen, D. Coakley, and B.A. Lawlor Sleep disturbance in mild to moderate Alzheimer's disease Sleep Med. 6 2005 347 352
8. K. Iijima, and K. Iijima-Ando Drosophila models of Alzheimer's amyloidosis: the challenge of dissecting the complex mechanisms of toxicity of amyloid-beta 42 J. Alzheimers Dis. 15 2008 523 540
9. A. Sehgal, and E. Mignot Genetics of sleep and sleep disorders Cell 146 2011 194 207
10. C. Nilsberth, A. Westlind-Danielsson, C.B. Eckman, M.M. Condron, K. Axelman, C. Forsell, C. Stenh, J. Luthman, D.B. Teplow, and S.G. Younkin The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation Nat. Neurosci. 4 2001 887 893
11. L. Xie, H. Kang, Q. Xu, M.J. Chen, Y. Liao, M. Thiyagarajan, J. O'Donnell, D.J. Christensen, C. Nicholson, and J.J. Iliff Sleep drives metabolite clearance from the adult brain Science 342 2013 373 377
12. G. Tononi, and C. Cirelli Sleep and the price of plasticity: from synaptic and cellular homeostasis to memory consolidation and integration Neuron 81 2014 12 34
13. G. Yang, C.S. Lai, J. Cichon, L. Ma, W. Li, and W.B. Gan Sleep promotes branch-specific formation of dendritic spines after learning Science 344 2014 1173 1178
14. F. Kamenetz, T. Tomita, H. Hsieh, G. Seabrook, D. Borchelt, T. Iwatsubo, S. Sisodia, and R. Malinow APP processing and synaptic function Neuron 37 2003 925 937
15. J.R. Cirrito, J.E. Kang, J. Lee, F.R. Stewart, D.K. Verges, L.M. Silverio, G. Bu, S. Mennerick, and D.M. Holtzman Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo Neuron 58 2008 42 51
16. J.R. Cirrito, K.A. Yamada, M.B. Finn, R.S. Sloviter, K.R. Bales, P.C. May, D.D. Schoepp, S.M. Paul, S. Mennerick, and D.M. Holtzman Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo Neuron 48 2005 913 922
17. A.W. Bero, P. Yan, J.H. Roh, J.R. Cirrito, F.R. Stewart, M.E. Raichle, J.M. Lee, and D.M. Holtzman Neuronal activity regulates the regional vulnerability to amyloid-beta deposition Nat. Neurosci. 14 2011 750 756
18. J.J. Palop, J. Chin, E.D. Roberson, J. Wang, M.T. Thwin, N. Bien-Ly, J. Yoo, K.O. Ho, G.Q. Yu, and A. Kreitzer Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease Neuron 55 2007 697 711
19. P.E. Sanchez, L. Zhu, L. Verret, K.A. Vossel, A.G. Orr, J.R. Cirrito, N. Devidze, K. Ho, G.Q. Yu, and J.J. Palop Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model Proc. Natl. Acad. Sci. USA 109 2012 E2895 E2903